Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility
- 1 December 2005
- journal article
- Published by Elsevier in Public Health
- Vol. 119 (12) , 1111-1115
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Hepatitis C Virus Infection Among Injection Drug UsersEpidemiology, 2004
- Updating the Infection Risk Reduction Hierarchy: Preventing Transition into InjectionJournal of Urban Health, 2004
- Drug consumption facilities: an update since 2000Drug and Alcohol Review, 2003
- The Potential Public Health and Community Impacts of Safer Injecting Facilities: Evidence From a Cohort of Injection Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug usersHepatology, 2002
- Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programmeAIDS, 2002
- Safer Injection Facilities in North America: Their Place in Public Policy and Health InitiativesJournal of Drug Issues, 2002
- Drug consumption facilities in Europe and the establishment of supervised injecting centres in AustraliaDrug and Alcohol Review, 2000
- The professional acceptance of drug use: a closer look at drug consumption rooms in the Netherlands, Germany and SwitzerlandInternational Journal of Drug Policy, 1999
- Methadone maintenance and hepatitis C virus infection among injecting drug usersAddiction, 1997